Endurance International Group to Announce 2016 First Quarter Financial Results on May 3, 2016
Apr 12, 2016 20:05 pm UTC| Business
BURLINGTON, Mass., April 12, 2016 -- Endurance International Group Holdings, Inc. (Nasdaq:EIGI), a leading provider of cloud-based platform solutions designed to help small and medium-sized businesses succeed online,...
Rapid7 to Report First Quarter 2016 Financial Results on May 11
Apr 12, 2016 20:05 pm UTC| Business
BOSTON, April 12, 2016 -- Rapid7, Inc. (NASDAQ:RPD), a leading provider of security data and analytics solutions, today announced that it will release its first quarter 2016 financial results on Wednesday, May 11, 2016...
McGrath RentCorp Sets First Quarter 2016 Financial Results Date and Time
Apr 12, 2016 20:05 pm UTC| Business
LIVERMORE, Calif., April 12, 2016 -- McGrath RentCorp (NASDAQ:MGRC) (the “Company”), a diversified business-to-business rental company, today announced that it plans to release financial results for its first quarter of...
DAVIDsTEA Inc. Opens Two New Stores in North America
Apr 12, 2016 20:02 pm UTC| Business
MONTREAL, April 12, 2016 -- DAVIDsTEA Inc. (NASDAQ:DTEA) (the “Company” or “DAVIDsTEA”) is pleased to announce the opening of two new North American stores: CrossIron Mills, AB, and Freehold Raceway Mall, NJ, featuring...
CSX Corporation Announces First Quarter Earnings
Apr 12, 2016 20:02 pm UTC| Business
Highlights: Service improvements, significant efficiency and resource alignment savings combined to help offset the impact of lower volumeContinued low commodity prices, strong U.S. dollar and energy market transition...
DAVIDsTEA Inc. Announces Fourth Quarter and Fiscal 2015 Financial Results
Apr 12, 2016 20:01 pm UTC| Business
Fourth quarter sales growth of 22.7% to C$75.8 million; comparable sales increase of 6.6% Fourth quarter adjusted EBITDA growth of 14.5% to C$18.9 million Fourth quarter adjusted net income of C$11.8 million or C$0.45...
Apr 12, 2016 20:01 pm UTC| Business
Primary endpoint of induction of amenorrhea met for both vaginal doses compared to placebo, p0.0011Proellex®-treated subjects reported a median 100% reduction in diary reports of menstrual bleeding product usage...